- Home
- AZ vs EBS Comparison
AZ vs EBS Comparison
Compare AZ & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZ
- EBS
- Stock Information
- Founded
- AZ 2018
- EBS 1998
- Country
- AZ Canada
- EBS United States
- Employees
- AZ N/A
- EBS N/A
- Industry
- AZ Industrial Machinery/Components
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- AZ Industrials
- EBS Health Care
- Exchange
- AZ Nasdaq
- EBS Nasdaq
- Market Cap
- AZ 319.5M
- EBS 359.3M
- IPO Year
- AZ N/A
- EBS 2006
- Fundamental
- Price
- AZ $8.11
- EBS $7.93
- Analyst Decision
- AZ Strong Buy
- EBS Strong Buy
- Analyst Count
- AZ 1
- EBS 3
- Target Price
- AZ $20.00
- EBS $14.33
- AVG Volume (30 Days)
- AZ 343.3K
- EBS 944.7K
- Earning Date
- AZ 11-12-2025
- EBS 11-05-2025
- Dividend Yield
- AZ N/A
- EBS N/A
- EPS Growth
- AZ N/A
- EBS N/A
- EPS
- AZ N/A
- EBS 2.53
- Revenue
- AZ $7,489,000.00
- EBS $851,600,000.00
- Revenue This Year
- AZ $1,343,857.60
- EBS N/A
- Revenue Next Year
- AZ N/A
- EBS $19.24
- P/E Ratio
- AZ N/A
- EBS $3.13
- Revenue Growth
- AZ 19.04
- EBS N/A
- 52 Week Low
- AZ $1.66
- EBS $4.02
- 52 Week High
- AZ $12.36
- EBS $12.73
- Technical
- Relative Strength Index (RSI)
- AZ 39.47
- EBS 48.37
- Support Level
- AZ $7.70
- EBS $7.75
- Resistance Level
- AZ $8.86
- EBS $8.13
- Average True Range (ATR)
- AZ 0.63
- EBS 0.37
- MACD
- AZ 0.02
- EBS -0.08
- Stochastic Oscillator
- AZ 19.34
- EBS 41.03
About AZ A2Z Smart Technologies Corp.
A2Z Cust2Mate Solutions Corp is engaged in creating shopping carts. With the help of a user-friendly smart algorithm, touch screen, and other technologies, the company streamlines the retail shopping experience by scanning purchased products and enabling in-cart payment so that customers can simply pick & go, and bypass long cashier checkout lines.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.